When adverse effects occurred, they were typically mild and transient, with the most common being mild to moderate headaches (similar frequency to placebo groups), minor injection site reactions (redness, slight swelling), and gastrointestinal effects at higher oral doses (nausea, diarrhea)
Proc Natl Acad Sci U S A 110(Suppl 2):1039510401
Our protocols use pharmaceutical-grade peptides from licensed compounding pharmacies, administered under direct NP supervision with ongoing monitoring
The solution should be completely clear with no visible particles, cloudiness, or discoloration
High quality supplements, doctor trusted with no fillers
On the other hand, when looking at the time above range measured by continuous glucose measuring, results were found to be 10.3% with the combined treatment, 28.1% with cagrilintide treatment, and 23.7% with semaglutide treatment [2]